SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Bausch Christoph Lawrence
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Kropotova Alexandra
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Sullivan Eddie Joe
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer King Michael
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Officer Reich Samuel J
SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Commodore Capital LP(3.5%),Commodore Capital Master LP(3.5%)
SAB Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-RTW Investments, LP(9.99%),Roderick Wong, M.D.(9.99%)
SAB Biotherapeutics | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-Radcliffe Capital Management, L.P.(0.00%),RGC Management Company, LLC(0.00%), etc.
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Chief Executive Officer Sullivan Eddie Joe
SAB Biotherapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-BVF Partners L.P.(9.99%),BVF Inc.(9.99%), etc.
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-CHIEF FINANCIAL OFFICER King Michael
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Executive Chairman Reich Samuel J
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sessa Capital (Master), L.P.
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Moin Andrew
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Ellias Helen K.
SAB Biotherapeutics | 3: Initial statement of beneficial ownership of securities-Director Ellias Helen K.
SAB Biotherapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Moin Andrew
SAB Biotherapeutics | 4/A: Statement of changes in beneficial ownership of securities (and amendment thereto)-Director Sessa Capital (Master), L.P.
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Moin Andrew
SAB Biotherapeutics | 4: Statement of changes in beneficial ownership of securities-Director Sessa Capital (Master), L.P.
No Data